List view / Grid view

News

Lapatinib clinical trial update

9 September 2011 | By GSK

A planned interim review of early data from ALTTO a Phase III, four arm study of adjuvant lapatinib (Tykerb/Tyverb®), trastuzumab, has resulted in a change to the ongoing study...

GSK awarded contract by BARDA

6 September 2011 | By GSK

GSK & the BARDA have agreed to a contract that will support the development by GSK of a potentially new antibiotic against both hospital Gram negative & biothreat pathogens...